Fukuda Denshi Co (TSE:6960) ROC %: 11.95% (As of Dec. 2025)


TSE:6960 Fukuda Denshi Co Ltd TSE:6960
79 GF Score
Price 円10,860.00
GF Value 円7,323.71
Valuation Significantly Overvalued
View Full Analysis

What is Fukuda Denshi Co ROC %?

Fukuda Denshi Co TSE:6960 +1.78% 79 ROC % is 11.95% as of Dec. 2025. GuruFocus rates TSE:6960 with a GF Score™ of 79/100 and a GF Value™ of 円7,323.71 (Significantly Overvalued).

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Fukuda Denshi Co's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was 11.95%.

As of today (2026-06-27), Fukuda Denshi Co's WACC % is 5.49%. Fukuda Denshi Co's ROC % is 13.56% (calculated using TTM income statement data). Fukuda Denshi Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Fukuda Denshi Co  (TSE:6960) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Fukuda Denshi Co's WACC % is 5.49%. Fukuda Denshi Co's ROC % is 13.56% (calculated using TTM income statement data). Fukuda Denshi Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Fukuda Denshi Co ROC % Related Terms


Fukuda Denshi Co ROC % Historical Data

* Premium members only.

The historical data trend for Fukuda Denshi Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fukuda Denshi Co ROC % Chart

Fukuda Denshi Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.08 14.20 14.46 13.33 13.31

Fukuda Denshi Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.99 8.17 14.03 11.95 19.95
TSE:6960
79GF Score
Fukuda Denshi Co Ltd TSE:6960
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fukuda Denshi Co ROC % Calculation

Fukuda Denshi Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=26608 * ( 1 - 30.48% )/( (132850 + 145034)/ 2 )
=18497.8816/138942
=13.31 %

where

Fukuda Denshi Co's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=22948 * ( 1 - 29.18% )/( (133253 + 138688)/ 2 )
=16251.7736/135970.5
=11.95 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 11.95% mean?
Fukuda Denshi Co (TSE:6960) has a ROC % of 11.95% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fukuda Denshi Co and its competitors.
Is Fukuda Denshi Co's ROC % too high?
Fukuda Denshi Co's current ROC % is 11.95%. The Medical Devices & Instruments industry median ROC % is 1.26. Fukuda Denshi Co's value of 11.95% is 848.4% above this industry median. Overall, Fukuda Denshi Co has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's ROC % compare to ABT and SYK?
Fukuda Denshi Co's ROC % of 11.95% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC % is 1.26. Fukuda Denshi Co's value of 11.95% is 848.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Devices & Instruments company?
The median ROC % among Medical Devices & Instruments companies is 1.26, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current ROC % of 11.95% is 848.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median ROC % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current ROC % is 11.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,323.71, compared to a current price of 円10,860.00 — trading 48.3% above its estimated fair value. The current ROC % is 11.95% and 848.4% above the Medical Devices & Instruments industry median of 1.26. Fukuda Denshi Co's overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current ROC % is 11.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?

Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued. The current stock price of 円10,860.00 is trading 48.3% above its estimated GF Value™ of 円7,323.71. GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.

Key valuation signals for TSE:6960:

  • ROC %: 11.95%
  • GF Value™: 円7,323.71 vs. price of 円10,860.00 (48.3% above fair value)
  • GF Score™: 79/100
  • Industry Position: 848.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fukuda Denshi Co Business Description

Address 39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
79GF Score

Get the complete analysis for TSE:6960

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円10,860.00
Price
円7,323.71
GF Value